Torrent Pharmaceuticals Ltd Quarterly Results

Gross Sales

2,909

2,762

2,831

2,815

2,695

Excise Duty

0

0

0

0

0

Net Sales

2,909

2,762

2,831

2,815

2,695

Other Operating Income

50

47

58

44

50

Other Income

-18

33

-16

24

31

Total Income

2,941

2,842

2,873

2,883

2,776

Total Expenditure

2,019

1,895

1,950

1,955

1,862

PBIDT

922

947

923

928

914

Interest

56

57

64

75

80

PBDT

866

890

859

853

834

Depreciation

201

199

198

197

203

Minority Interest Before NP

0

0

0

0

0

Tax

184

153

156

126

142

Deferred Tax

-17

35

52

73

40

Reported Profit After Tax

498

503

453

457

449

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

498

503

453

457

449

Extra-ordinary Items

-17.36

0

0

0

0

Adjusted Profit After Extra-ordinary item

515.36

503

453

457

449

EPS (Unit Curr.)

14.71

14.88

13.37

13.51

13.27

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

520

0

0

0

Equity

169.23

169.23

169.23

169.23

169.23

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

31.69

34.28

32.6

32.96

33.91

PBDTM(%)

29.76

32.22

30.34

30.3

30.94

PATM(%)

17.11

18.21

16

16.23

16.66